Niki BioSolutions, Inc.

FY: Dec 31 2025

FY: Dec 31 2024

FY: Dec 31 2023

FY: Dec 31 2022

FY: Dec 31 2021

FY: Dec 31 2021

FY: Dec 31 2020

FY: Dec 31 2019

FY: Dec 31 2018

FY: Dec 31 2018

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Financial Statements and Exhibits

Financial Statements and Exhibits

Other Events

Completion of Acquisition or Disposition of Assets

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Withdrawal of a registration statement

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement for securities of certain foreign private issuers

Prospectus Supplement for Primary Offering

Notice of Effectiveness

No description available

Registration statement for securities of certain foreign private issuers

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Arner Douglas Wayne

Wu Justin Che Yuen

Mireskandari Alidad

Philips Laura A

Sheinerman Kira

Sheinerman Kira

L1 Capital Global Opportunities Master Fund, Ltd.

SCOGGIN MANAGEMENT LP

L1 Capital Global Opportunities Master Fund, Ltd.

none

none

none

none

none

Hudson Bay Capital Management LP

none

none

none

none

none

Draft registration statement (confidential submission)

Draft registration statement (confidential submission)

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC